259 – Drug Targets for HIV
#
English - September 26, 2020 15:30 - 38 minutes - 34.5 MB - ★★★★★ - 239 ratingsNatural Sciences Science Education biotech science life science plant biology agriculture agtech biology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Tweet
The human immunodeficiency virus remains prevalent in the population, yet it as silently moved out of the public’s consciousness, overshadowed by COVID19 and drug cocktails that can control its progression. Over the last three decades great progress has been made in understanding the virus and how it interacts with cells. This, plus the identification of genetic determinants of resistance to HIV have presented researchers with new drug targets. These may represent future therapies and perhaps cures. Today’s guest is Dr. Luca Vangelista from Nazarbayev University in Kazakhstan. His research examines a protein receptor called CCR5 that is a critical player in the HIV infection cycle.
Dr. Vangelista’s recent review may be accessed here.
Here is Dr. Vangelista’s website.
